These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of Beta-blockers as first-line therapy in hypertension. De Caterina AR; Leone AM Curr Atheroscler Rep; 2011 Apr; 13(2):147-53. PubMed ID: 21207202 [TBL] [Abstract][Full Text] [Related]
23. Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach. Stienen U; Meyer-Sabellek W Clin Investig; 1992; 70 Suppl 1():S65-72. PubMed ID: 1350487 [TBL] [Abstract][Full Text] [Related]
24. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW; Laugerotte A; Wright JM Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578 [TBL] [Abstract][Full Text] [Related]
25. Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension. Bakris GL; Weber MA Rev Cardiovasc Med; 2008; 9(2):96-105. PubMed ID: 18660730 [TBL] [Abstract][Full Text] [Related]
27. A new molecule with vasodilating and beta-adrenoceptor blocking properties. Abshagen U J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364 [TBL] [Abstract][Full Text] [Related]
28. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. McTavish D; Campoli-Richards D; Sorkin EM Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374 [TBL] [Abstract][Full Text] [Related]